0001192482-19-000443.txt : 20191122 0001192482-19-000443.hdr.sgml : 20191122 20191122170345 ACCESSION NUMBER: 0001192482-19-000443 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191121 FILED AS OF DATE: 20191122 DATE AS OF CHANGE: 20191122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Recro Pharma, Inc. CENTRAL INDEX KEY: 0001588972 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39101 FILM NUMBER: 191242418 BUSINESS ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (484) 395-2400 MAIL ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Baudax Bio, Inc. CENTRAL INDEX KEY: 0001780097 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 474639500 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 484-395-2470 MAIL ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: Recro Enterprises, Inc. DATE OF NAME CHANGE: 20190618 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-11-21 1 0001780097 Baudax Bio, Inc. BXRX 0001588972 Recro Pharma, Inc. 490 LAPP ROAD MALVERN, PA 19355 0 0 1 0 Common Stock 2019-11-21 4 J 0 9211145 0 A 9211245 D Common Stock 2019-11-21 4 J 0 9211245 0 D 0 D On November 21, 2019, Baudax Bio, Inc. ("Baudax") issed 9,211,145 shares of its common stock to its parent, Recro Pharma, Inc. ("Recro"). On November 21, 2019, Recro made a pro rata distribution of 100% of the outstanding shares of Baudax common stock to Recro stockholders of record as of November 15, 2019, the record date for the distribution. Ryan D. Lake, Chief Financial Officer on behalf of Recro Pharma, Inc. 2019-11-22